Literature DB >> 21419427

Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Marius Birlea1, Gabriele Arendt, Eser Orhan, D Scott Schmid, William J Bellini, Christian Schmidt, Don Gilden, Randall J Cohrs.   

Abstract

Analysis of 200 paired serum and cerebrospinal fluid (CSF) samples from 180 HIV-positive individuals, 136 of whom had AIDS, revealed intrathecal synthesis of antibodies specific for varicella zoster virus (VZV) in 28 (16%) individuals, measles virus in 15 (8%), herpes simplex virus-1 (HSV-1) in 1 (0.6%), and HSV-2 in none. Of the 28 subjects with a positive VZV antibody specificity index, only 1 had zoster rash at the time of serum and CSF sampling; of the total 180 HIV-positive subjects, 146 (81%) had no history of zoster. Based on an estimated 33.4 million HIV-positive individuals worldwide, subclinical reactivation of VZV in even less than 16% of HIV-positive people suggests the possibility that millions of people have active VZV infection of the central nervous system. In cases of VZV vasculopathy, myelopathy and even zoster sine herpete, the CSF is often positive for anti-VZV antibody, but negative for VZV DNA. To rule out VZV infection of the nervous system, CSF must be tested for VZV DNA and anti-VZV IgG and IgM antibody.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21419427      PMCID: PMC3176733          DOI: 10.1016/j.jns.2011.02.030

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Zoster sine herpete: virologic verification by detection of anti-VZV IgG antibody in CSF.

Authors:  D T Blumenthal; E Shacham-Shmueli; F Bokstein; D S Schmid; R J Cohrs; M A Nagel; R Mahalingam; D Gilden
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

2.  Complications of varicella zoster virus reactivation in HIV-infected homosexual men.

Authors:  J Veenstra; R M van Praag; A Krol; P M Wertheim van Dillen; H M Weigel; P T Schellekens; J M Lange; R A Coutinho; J T van der Meer
Journal:  AIDS       Date:  1996-04       Impact factor: 4.177

3.  Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection.

Authors:  A De La Blanchardiere; F Rozenberg; E Caumes; O Picard; F Lionnet; J Livartowski; J Coste; D Sicard; P Lebon; D Salmon-Cèron
Journal:  Scand J Infect Dis       Date:  2000

4.  Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.

Authors:  P Ljungman; B Lönnqvist; G Gahrton; O Ringdén; V A Sundqvist; B Wahren
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

5.  Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.

Authors:  A A Gershon; N Mervish; P LaRussa; S Steinberg; S H Lo; D Hodes; S Fikrig; V Bonagura; S Bakshi
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

6.  Polymerase chain reaction detection and clinical significance of varicella-zoster virus in cerebrospinal fluid from human immunodeficiency virus-infected patients.

Authors:  D G Burke; R C Kalayjian; V R Vann; S A Madreperla; H E Shick; D G Leonard
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

Review 7.  Zoster sine herpete, a clinical variant.

Authors:  D H Gilden; R R Wright; S A Schneck; J M Gwaltney; R Mahalingam
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

8.  Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.

Authors:  M J Glesby; R D Moore; R E Chaisson
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

9.  Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain.

Authors:  H Reiber; P Lange
Journal:  Clin Chem       Date:  1991-07       Impact factor: 8.327

10.  Virological markers in the cerebrospinal fluid from HIV-1-infected individuals.

Authors:  R Buffet; H Agut; F Chieze; C Katlama; F Bolgert; A Devillechabrolle; B Diquet; E Schuller; C Pierrot-Deseilligny; M Gentilini
Journal:  AIDS       Date:  1991-12       Impact factor: 4.177

View more
  15 in total

1.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

Review 2.  Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review.

Authors:  Jessica Leung; Karen R Broder; Mona Marin
Journal:  Expert Rev Vaccines       Date:  2017-02-28       Impact factor: 5.217

Review 3.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

4.  Varicella-Zoster meningitis with normal CSF cellularity: A rare case report.

Authors:  Bana Sabbagh; Mohammed Najdat Seijari; Mhd Kutaiba Albuni; Munsef Barakat; Gamal B Alfitori
Journal:  IDCases       Date:  2022-03-25

5.  Varicella zoster virus (VZV) in cerebral arteries of subjects at high risk for VZV reactivation.

Authors:  Maria A Nagel; Nelly Khmeleva; Alexander Choe; Jose Gutierrez; Don Gilden
Journal:  J Neurol Sci       Date:  2014-02-08       Impact factor: 3.181

Review 6.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Varicella zoster vaccines and their implications for development of HSV vaccines.

Authors:  Anne A Gershon
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

8.  Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review.

Authors:  Susannah L McKay; Angela Guo; Steven A Pergam; Kathleen Dooling
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

9.  Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV.

Authors:  Monique van Velzen; Werner J D Ouwendijk; Stacy Selke; Suzan D Pas; Freek B van Loenen; Albert D M E Osterhaus; Anna Wald; Georges M G M Verjans
Journal:  J Med Virol       Date:  2013-06-18       Impact factor: 2.327

10.  Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia.

Authors:  Srinivas Nalamachu; Matthew Wieman; Leah Bednarek; Surya Chitra
Journal:  Patient Prefer Adherence       Date:  2013-06-18       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.